US Stock MarketDetailed Quotes

Psyence Biomedical (PBM)

Watchlist
  • 2.670
  • +0.170+6.80%
Close Apr 10 15:59 ET
  • 2.550
  • -0.120-4.49%
Post 20:01 ET
3.06MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Psyence Biomedical (PBM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(FY)Mar 31, 2025
(Q2)Sep 30, 2024
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(FY)Mar 31, 2023
(Q2)Sep 30, 2022
(FY)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.18%1.51M
-91.72%3.66M
556.84%1.16M
1,267.39%44.23M
-27.80%176.17K
74.30%3.23M
244K
1.86M
Selling and administrative expenses
28.87%1.15M
84.56%3.32M
382.11%890.48K
10.52%1.8M
-23.72%184.7K
-5.40%1.63M
--242.15K
--1.72M
-Selling and marketing expense
-82.22%48.67K
499.89%483.53K
24,856.06%273.77K
1,046.72%80.6K
--1.1K
-59.86%7.03K
--0
--17.51K
-General and administrative expense
78.18%1.1M
65.06%2.83M
235.88%616.71K
6.02%1.72M
-24.18%183.61K
-4.84%1.62M
--242.15K
--1.7M
Research and development costs
34.57%357.44K
-64.16%342.17K
3,210.74%265.63K
-40.67%954.59K
-561.03%-8.54K
1,072.35%1.61M
--1.85K
--137.24K
Depreciation amortization depletion
30.91%1.33K
1,678.33%4.27K
--1.02K
--240
--0
--0
----
----
-Depreciation and amortization
30.91%1.33K
1,678.33%4.27K
--1.02K
--240
--0
--0
----
----
Other operating expenses
----
----
----
--41.48M
----
----
----
----
Operating profit
-30.18%-1.51M
91.72%-3.66M
-556.84%-1.16M
-1,267.39%-44.23M
27.80%-176.17K
-74.30%-3.23M
-244K
-1.86M
Net non-operating interest income expense
1,985.92%70.06K
270.29%86.52K
86.70%-3.72K
-3,369.43%-50.81K
-3,605.02%-27.94K
1.55K
797.0283
0
Non-operating interest income
--72.82K
4,388.61%95.79K
--0
37.32%2.13K
----
--1.55K
----
--0
Non-operating interest expense
-25.90%2.75K
-82.49%9.27K
-86.70%3.72K
--52.94K
--27.94K
--0
----
----
Total other finance cost
----
----
----
----
----
----
---797.0283
----
Other net income (expense)
-47.56%682.99K
166.74%4.59M
1,333.47%1.3M
-25,645.52%-6.87M
-7,101.52%-105.58K
1,276.42%26.91K
-1.47K
-2.29K
Gain on sale of security
475.84%682.99K
269.97%525.1K
-72.12%-181.73K
-1,247.98%-308.95K
-7,101.52%-105.58K
1,276.42%26.91K
---1.47K
---2.29K
Special income (charges)
----
--0
----
---2.18M
----
--0
----
----
-Less：Restructuring and merger&acquisition
----
--0
----
--2.46M
----
--0
----
----
-Less:Other special charges
----
----
----
---281.5K
----
----
----
----
Other non- operating income (expenses)
----
192.63%4.06M
--1.48M
---4.39M
----
----
----
----
Income before tax
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Income tax
Net income
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Net income continuous Operations
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
---244.67K
---1.86M
Minority interest income
Net income attributable to the parent company
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Basic earnings per share
-112.53%-3.1875
101.83%261.0175
128.02%25.4375
-1,418.51%-14.27K
-26.57%-90.7892
-72.55%-940.0185
-71.7289
-544.7772
Diluted earnings per share
-112.53%-3.1875
101.83%261.0175
128.02%25.4375
-1,418.51%-14.27K
-26.57%-90.7892
-72.55%-940.0185
-71.7289
-544.7772
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q2)Sep 30, 2025(FY)Mar 31, 2025(Q2)Sep 30, 2024(FY)Mar 31, 2024(Q2)Sep 30, 2023(FY)Mar 31, 2023(Q2)Sep 30, 2022(FY)Mar 31, 2022
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.18%1.51M-91.72%3.66M556.84%1.16M1,267.39%44.23M-27.80%176.17K74.30%3.23M244K1.86M
Selling and administrative expenses 28.87%1.15M84.56%3.32M382.11%890.48K10.52%1.8M-23.72%184.7K-5.40%1.63M--242.15K--1.72M
-Selling and marketing expense -82.22%48.67K499.89%483.53K24,856.06%273.77K1,046.72%80.6K--1.1K-59.86%7.03K--0--17.51K
-General and administrative expense 78.18%1.1M65.06%2.83M235.88%616.71K6.02%1.72M-24.18%183.61K-4.84%1.62M--242.15K--1.7M
Research and development costs 34.57%357.44K-64.16%342.17K3,210.74%265.63K-40.67%954.59K-561.03%-8.54K1,072.35%1.61M--1.85K--137.24K
Depreciation amortization depletion 30.91%1.33K1,678.33%4.27K--1.02K--240--0--0--------
-Depreciation and amortization 30.91%1.33K1,678.33%4.27K--1.02K--240--0--0--------
Other operating expenses --------------41.48M----------------
Operating profit -30.18%-1.51M91.72%-3.66M-556.84%-1.16M-1,267.39%-44.23M27.80%-176.17K-74.30%-3.23M-244K-1.86M
Net non-operating interest income expense 1,985.92%70.06K270.29%86.52K86.70%-3.72K-3,369.43%-50.81K-3,605.02%-27.94K1.55K797.02830
Non-operating interest income --72.82K4,388.61%95.79K--037.32%2.13K------1.55K------0
Non-operating interest expense -25.90%2.75K-82.49%9.27K-86.70%3.72K--52.94K--27.94K--0--------
Total other finance cost ---------------------------797.0283----
Other net income (expense) -47.56%682.99K166.74%4.59M1,333.47%1.3M-25,645.52%-6.87M-7,101.52%-105.58K1,276.42%26.91K-1.47K-2.29K
Gain on sale of security 475.84%682.99K269.97%525.1K-72.12%-181.73K-1,247.98%-308.95K-7,101.52%-105.58K1,276.42%26.91K---1.47K---2.29K
Special income (charges) ------0-------2.18M------0--------
-Less：Restructuring and merger&acquisition ------0------2.46M------0--------
-Less:Other special charges ---------------281.5K----------------
Other non- operating income (expenses) ----192.63%4.06M--1.48M---4.39M----------------
Income before tax -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Income tax
Net income -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Net income continuous Operations -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M---244.67K---1.86M
Minority interest income
Net income attributable to the parent company -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Basic earnings per share -112.53%-3.1875101.83%261.0175128.02%25.4375-1,418.51%-14.27K-26.57%-90.7892-72.55%-940.0185-71.7289-544.7772
Diluted earnings per share -112.53%-3.1875101.83%261.0175128.02%25.4375-1,418.51%-14.27K-26.57%-90.7892-72.55%-940.0185-71.7289-544.7772
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -